Rheumatology Drugs at a Glance, Part 1: Psoriatic Arthritis
Rheumatology Drug Updates: Hip Fracture Rates After Bisphosphonate Drug Holidays, Plus More on Golimumab, Ustekinumab
Johnson & Johnson Discloses U.S. Probe Related to Arthritis Drugs
High Cost of Rheumatoid Arthritis Medications Burdens Patients in Saudi Arabia
FDA Releases Biosimilar Guidance, Medicare Will Cover Infliximab-dyyb & More
Golimumab Effective as Maintenance Treatment for Active Ulcerative Colitis
Clinical Trials: Zilretta Promising for Knee OA Pain & Golimumab Completes Phase 3 Trial